ERBB2 and breast carcinoma: To study the molecular mechanism by which MM-121 overcomes paclitaxel resistance and increases paclitaxel-mediated anti-proliferative/anti-survival effects in the studied erbB2-overexpressing breast cancer cell lines, we investigated whether MM-121 might enhance paclitaxel-induced apoptosis.